Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer

Gynecologic Oncology

Volumn 65, Issue 3, 1997, Pages 512-516

  Lambert Messerlian, G M ^a   Steinhoff, M ^a   Zheng, W ^a   Canick, J A ^a   Gajewski, W H ^a   Seifer, D B ^b   Schneyer, A L ^c  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER RISK; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; OVARY CANCER; OVARY CARCINOMA; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0031172116     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4719     Document Type: Article

References (23)

1. 1. Boring C, Squires T, Tong T: Cancer statistics. Am Cancer J Clin 43:7-26, 1993
2. 2. Montag TW: Tumor markers in gynecologic oncology. Obstet Gynecol Surv 45:94-105, 1990
3. 3. Zeimet AG, et al: Tumor marker CA 125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle. Fertil Steril 59:1028-1035, 1993
4. 4. Jacobs I, Bast RC: The CA 125 tumour associated antigen: a review of the literature. Hum Reprod 4:1-12, 1989
5. 5. McLachlan RI, Robertson DM, Burger HG, DeKretser DM: The radio-immunoassay of bovine and human follicular fluid and serum inhibin. Mol Cell Endocrinol 46:175-185, 1986
6. 6. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, DeBruijn HWA: Inhibin as a marker for granulosa cell tumors. N Engl J Med 321:790-793, 1989
7. 7. Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R, Campbell JJ: Elevated serum inhibin concentrations in post-menopausal women with ovarian tumors. N Engl J Med 329:1539-1542, 1993
8. 8. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P, Spiess J, Rivier J: Chemical and biological characterization of the inhibin family of proteins. Rec Prog Horm Res 44:1-34, 1988
9. 9. DeKretser DM, Robertson DM: The isolation and physiology of inhibin and related proteins. Biol Reprod 40:33-47, 1989
10. 10. Schneyer AL, Sluss PM, Whitcomb RW, Martin KA, Sprengel R, Crowley WF Jr: Precursors of α-inhibin modulate FSH receptor binding and biological activity. Endocrinology 129:1987-1999, 1991
11. 11. Schneyer AL, Mason AJ, Burton LE, Zeigner JR, Crowley WF Jr: Immunoreactive inhibin α subunit in human serum: implications for RIA. J Clin Endocrinol Metab 70:1208-1212, 1990
12. 12. Lambert-Messerlian GM, Isaacson K, Crowley WF Jr, Sluss P, Schneyer AL: Human follicular fluid contains pro-and C-terminal immunoreactive α-inhibin precursor proteins. J Clin Endocrinol Metab 78:433-439, 1994
13. 13. Robertson DM, Giacometti M, Foulds LM, Lahnstein J, Goss NH, Hearn MTW, DeKretser DM: Isolation of inhibin α-subunit precursor proteins from bovine follicular fluid. Endocrinology 125:2141-2149, 1989
14. 14. Burger HG, Robertson DM, Cahir N, Mamers P, Healy DL, Jobling T, Groome N: Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumors. Clin Endocrinol 44:413-418, 1996
15. 15. Lambert-Messerlian GM, Hall JE, Sluss PM, Taylor AE, Martin KA, Groome NP, Crowley WF Jr, Schneyer AL: Relatively low levels of dimeric inhibin circulate in men and women with polycystic ovarian syndrome using a specific two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 79:45-50, 1994
16. 16. Groome NP, Illingworth PJ, O'Brien M, Priddle J, Weaver K, McNeilly AS: Quantification of inhibin pro-αC-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 80:2926-2932, 1995
17. 17. Robertson D, Burger HG, Sullivan J, Cahir N, Groome N, Poncelet E, Franchimont P, Woodruff T, Mather JP: Biological and immunological characterization of inhibin forms in human plasma. J Clin Endocrinol Metab 81:669-676, 1996
18. 18. Cooke I, O'Brien M, Charnock FM, Groome N, Ganesan TS: Inhibin as a marker for ovarian cancer. Br J Cancer 71:1046-1050, 1995
19. 19. Burger HG, Fuller PJ: The inhibin/activin family and ovarian cancer. Trends Endocrinol Metab 7:197-202, 1996
20. 20. Gurusinghe CJ, Healy DL, Jobling T, Mamers P, Burger HG: Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 57:27-32, 1995
21. 21. Zheng W, Sung CJ, Hanna I, DePetris G, Lambert-Messerlian G, Steinhoff M, Lauchlan SC: α and β subunits of inhibin/activin as sex cord-stromal differentiation markers. Int J Gynecol Pathol, in press, 1997
22. 22. DiSimone N, Crowley WF Jr, Wang QF, Sluss PM, Schneyer AL: Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology 137:486-494, 1996
23. 23. Matzuk MM, Finegold MJ, Su JJ, Hsueh AJW, Bradley A: α-inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 360:313-319, 1992